Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
AR protein | 7 | 0 | 0 | 7 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
PPM1D protein | 2 | 0 | 0 | 2 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
TDP1 protein | 2 | 0 | 0 | 2 |
Thrombopoietin | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
polyprotein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
geminin | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 4 | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Lethal factor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Endothelin-1 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 3 | 1 | 4 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Melanocortin receptor 3 | 0 | 3 | 1 | 4 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TBK1 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 1 | 4 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Glucagon-like peptide 1 receptor | 0 | 0 | 1 | 1 |
Glucagon-like peptide 1 receptor | 0 | 1 | 1 | 2 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Chain A, Fatty acid-binding protein, adipocyte | 0 | 1 | 0 | 1 |
GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Toll-like receptor 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 1 | 3 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 2 | 1 | 3 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 1 | 2 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Melanocyte-stimulating hormone receptor | 0 | 1 | 1 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |